½ÃÀ庸°í¼­
»óǰÄÚµå
1542776

¼¼°èÀÇ °ü»óµ¿¸Æ °¡À̵å¿ÍÀÌ¾î ½ÃÀå

Coronary Guidewires

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Industry Analysts, Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 174 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

°ü»óµ¿¸Æ °¡À̵å¿ÍÀÌ¾î ¼¼°è ½ÃÀåÀº 2030³â±îÁö 8¾ï 720¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù

2023³â 5¾ï 9,720¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â °ü»óµ¿¸Æ °¡À̵å¿ÍÀÌ¾î ¼¼°è ½ÃÀåÀº 2023-2030³â°£ÀÇ ºÐ¼® ±â°£ µ¿¾È ¿¬Æò±Õ 4.4% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 8¾ï 720¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ´ÏƼ³î ±â¹Ý °¡À̵å¿ÍÀ̾î´Â CAGR 2.9%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ ¸»¿¡ 5¾ï 5,020¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ºÆ¿ º£À̽º °¡À̵å¿ÍÀÌ¾î ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 8.3%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀå 1¾ï 6,080¸¸ ´Þ·¯, Áß±¹Àº CAGR 4.3%·Î ¼ºÀå Àü¸Á

¹Ì±¹ÀÇ °ü»óµ¿¸Æ °¡À̵å¿ÍÀÌ¾î ½ÃÀåÀº 2023³â 1¾ï 6,080¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö ½ÃÀå ±Ô¸ð°¡ 1¾ï 2,890¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023-2030³â°£ÀÇ ºÐ¼® ±â°£ µ¿¾È 4.3%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 4.2%¿Í 3.6%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ ¿¬Æò±Õ 3.7%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è °ü»óµ¿¸Æ °¡À̵å¿ÍÀÌ¾î ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

Áõ°¡ÇÏ´Â ½ÉÀ庴: Àü ¼¼°èÀûÀ¸·Î È®´ëµÇ´Â ½ÉÀ庴 À§±â

½ÉÇ÷°ü°è Áúȯ(CVDs)Àº Àü ¼¼°èÀûÀ¸·Î ½É°¢ÇÑ ¼Óµµ·Î Áõ°¡Çϰí ÀÖÀ¸¸ç, Àü ¼¼°è »ç¸Á ¿øÀÎ 1À§·Î ²ÅÈ÷°í ÀÖ½À´Ï´Ù. °í·ÉÈ­, µµ½ÃÈ­, »ýȰ½À°üÀÇ º¯È­(°Ç°­¿¡ ÇØ·Î¿î À½½Ä ¼·Ãë Áõ°¡, ½ÅüȰµ¿ °¨¼Ò, ´ã¹è »ç¿ë µî)°¡ ½ÉÀåÁúȯÀÇ È®»ê¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. Çö´ëÀÎÀÇ »ýȰ½À°üÀº °íÇ÷¾Ð, ºñ¸¸, ´ç´¢º´°ú °°Àº À§Çè¿äÀÎÀ» À¯¹ßÇϱ⠽¬¿ï »Ó¸¸ ¾Æ´Ï¶ó, Áõ°¡ÇÏ´Â ½ÉÀå °ü·Ã ÁúȯÀ» °ü¸®ÇÏ´Â µ¥ ÀÖ¾î ÀÇ·á ½Ã½ºÅÛÀÌ Á÷¸éÇÑ ¹®Á¦¸¦ ´õ¿í ¾ÇÈ­½Ã۰í ÀÖ½À´Ï´Ù. ¸Å³â ¼ö¹é¸¸ ¸íÀÇ »ç¶÷µéÀÌ CVD Áø´ÜÀ» ¹Þ°í ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ Áõ°¡ Ãß¼¼¸¦ ¸·±â À§Çؼ­´Â ¿¹¹æ Á¶Ä¡ °­È­, º¸´Ù ±¤¹üÀ§ÇÑ °øÁߺ¸°Ç Ä·ÆäÀÎ, º¸´Ù Á¢±ÙÇϱ⠽¬¿î Ä¡·á ¿É¼ÇÀÌ ½Ã±ÞÈ÷ ÇÊ¿äÇÏ´Ù´Â Á¡ÀÌ °­Á¶µÇ°í ÀÖ½À´Ï´Ù. °¢±¹ÀÌ ÀÚ±¹¹ÎÀÇ ÀÇ·á ¼ö¿ä¸¦ ÃæÁ·½Ã۱â À§ÇØ ³ë·ÂÇÏ´Â °¡¿îµ¥, ¼ö¹é¸¸ ¸íÀÇ ½ÉÀå °Ç°­ÀÌ À§Çè¿¡ Ã³ÇØ ÀÖÀ¸¸ç, Àü ¼¼°è Á¤ºÎ¿Í Á¶Á÷Àº ½ÉÇ÷°ü Ä¡·á¿Í ¿¬±¸¸¦ ¿ì¼±¼øÀ§¿¡ µÎ¾î¾ß ÇÕ´Ï´Ù.

½ÉÀåÀÇ ¹Ì·Î Ž»ö : °ü»ó µ¿¸Æ °¡À̵å¿ÍÀ̾î´Â ¾î¶»°Ô º¯È­¸¦ °¡Á®¿Ã ¼ö Àִ°¡?

°ü»óµ¿¸Æ °¡À̵å¿ÍÀ̾î´Â ½ÉÀå Àü¹®Àǰ¡ Ç÷°ü ¼ºÇü¼úÀ̳ª ½ºÅÙÆ® »ðÀÔ°ú °°Àº ½Ã¼ú ½Ã ½ÉÀåÀÇ º¹ÀâÇÑ Ç÷°ü ½Ã½ºÅÛÀ» Ž»öÇϱâ À§ÇØ »ç¿ëÇÏ´Â °¡´À´Ù¶õ ¿ÍÀ̾îÀÔ´Ï´Ù. ÀÌ ¿ÍÀ̾î´Â Ä«Å×ÅÍ ¹× ±âŸ ±â±¸¸¦ ¾È³»ÇÏ´Â ¿ªÇÒÀ» Çϸç, °ü»óµ¿¸Æ ÁúȯÀÇ Áõ»óÀ¸·Î ÈçÈ÷ ³ªÅ¸³ª´Â ¸·È÷°Å³ª Á¼¾ÆÁø µ¿¸ÆÀ» Á¤È®ÇÏ°Ô Ã£¾Æ³»¾î Ä¡·áÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. °ü»óµ¿¸Æ °¡À̵å¿ÍÀ̾îÀÇ À¯¿¬¼º°ú °­µµ´Â ¼Õ»ó ¾øÀÌ ¼¶¼¼ÇÑ Ç÷°üÀ» ¾ÈÀüÇÏ°Ô °¡·ÎÁú·¯¾ß Çϱ⠶§¹®¿¡ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÀϹÝÀûÀ¸·Î ½ºÅ×Àθ®½º ½ºÆ¿ ¶Ç´Â ´ÏƼ³î ÄÚ¾î·Î ¸¸µé¾îÁø ÀÌ ¿ÍÀ̾î´Â ¸¶ÂûÀ» ÁÙÀ̴ ģ¼ö¼º ÄÚÆÃÀÌ Àû¿ëµÇ¾î Á¼°í ±¸ºÒ±¸ºÒÇÑ µ¿¸Æ °æ·Î¸¦ º¸´Ù ¿øÈ°ÇÏ°Ô Åë°úÇÒ ¼ö ÀÖµµ·Ï ¼³°èµÇ¾î ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¤¹ÐÇÑ Á¶ÀÛ¼ºÀº ÁßÀçÀû ½Ã¼úÀÇ ¼º°ø¿¡ ÇʼöÀûÀ̸ç, ÀûÀýÇÑ Ç÷·ù¸¦ ȸº¹ÇÏ°í ½ÉÀ帶ºñ À§ÇèÀ» ÁÙÀÓÀ¸·Î½á ȯÀÚÀÇ ¿¹ÈÄ¿¡ Á÷Á¢ÀûÀÎ ¿µÇâÀ» ¹ÌĨ´Ï´Ù.

°ü»óµ¿¸Æ °¡À̵å¿ÍÀ̾îÀÇ ¹Ì·¡¸¦ ¹Ù²Ü Çõ½ÅÀ̶õ?

ÃÖ±Ù °ü»óµ¿¸Æ °¡À̵å¿ÍÀ̾îÀÇ ÁøÈ­´Â Ä«Å×ÅÍ ½Ã¼úÀÇ »ç¿ë ÆíÀǼº°ú È¿À²¼ºÀ» ³ôÀ̱â À§ÇÑ ±â¼ú ¹ßÀüÀ¸·Î Ư¡Áö¾îÁý´Ï´Ù. Ãֽа¡À̵å¿ÍÀ̾î´Â Àǻ簡 º¸´Ù Á¤È®ÇÏ°Ô ¿ÍÀ̾ À¯µµÇÒ ¼ö ÀÖµµ·Ï ÅäÅ© Á¦¾î¸¦ °­È­ÇÏ´Â µî ÷´Ü ±â´ÉÀ» °®Ãß°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÇÏÀ̺긮µå °¡À̵å¿ÍÀ̾îÀÇ °³¹ß·Î ¿ÍÀ̾îÀÇ ´Ù¾çÇÑ ºÎºÐ¿¡ À¯¿¬¼º ¹× °­¼º°ú °°Àº ´Ù¾çÇÑ ±â´ÉÀ» °áÇÕÇÏ¿© ƯÁ¤ ½Ã¼úÀÇ ¿ä±¸¿Í º¹À⼺À» ÃæÁ·½Ãų ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. Àç·á °úÇÐÀÇ Çõ½ÅÀº ÃßÀû¼ºÀ» °³¼±Çϰí Ç÷°ü ¿Ü»óÀ» °¨¼Ò½ÃŰ´Â ¸¶ÀÌÅ©·Î ÄÚÆÃµÈ Ç¥¸éÀ» °¡Áø °¡À̵å¿ÍÀ̾îÀÇ »ý»êÀ¸·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀû °³¼±Àº º¸´Ù ¾ÈÀüÇϰí È¿À²ÀûÀÎ ½Ã¼úÀ» °¡´ÉÇÏ°Ô ÇÒ »Ó¸¸ ¾Æ´Ï¶ó, º¸´Ù º¹ÀâÇÑ °ü»óµ¿¸Æ Áúȯ¿¡ ´ëÇÑ ÃÖ¼Òħ½ÀÀû ½Ã¼úÀÇ °¡´É¼ºÀ» ³ÐÇôÁÖ°í ÀÖ½À´Ï´Ù.

°ü»óµ¿¸Æ °¡À̵å¿ÍÀ̾îÀÇ »ç¿ë¿¡´Â ¾î¶² µµÀü°ú À§ÇèÀÌ Àִ°¡?

½ÉÀå Ä«Å×ÅÍ Ä¡·á¿¡¼­ Áß¿äÇÑ ¿ªÇÒ¿¡µµ ºÒ±¸ÇÏ°í °ü»óµ¿¸Æ °¡À̵å¿ÍÀ̾îÀÇ »ç¿ë¿¡ À§Çè°ú ¹®Á¦°¡ ¾ø´Â °ÍÀº ¾Æ´Õ´Ï´Ù. ÁÖ¿ä ¿ì·Á »çÇ× Áß Çϳª´Â ¿ÍÀ̾ ½Ç¼ö·Î Ç÷°ü °æ·Î¿¡¼­ ¹þ¾î³¯ °æ¿ì ¹ß»ýÇÒ ¼ö ÀÖ´Â µ¿¸Æ ¼Õ»óÀÇ °¡´É¼ºÀÔ´Ï´Ù. ÀÌ·¯ÇÑ »ç°í´Â µå¹°Áö¸¸ Ç÷°ü õ°ø ¹× ÈÄ¼Ó ÃâÇ÷À» Æ÷ÇÔÇÑ ½É°¢ÇÑ ÇÕº´ÁõÀ¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ƯÁ¤ ½Ã¼ú¿¡ ÀûÇÕÇÑ °¡À̵å¿ÍÀ̾ ¼±ÅÃÇÏ´Â °ÍÀº ȯÀÚÀÇ °ü»óµ¿¸Æ ÇØºÎÇÐÀû Ư¼º¿¡ µû¶ó ´Þ¶óÁö±â ¶§¹®¿¡ ¼ö¼ú ´ã´ç ÀÇ»çÀÇ ¼÷·Ãµµ¿Í °æÇèÀÌ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ¶ÇÇÑ, °¡À̵å¿ÍÀ̾ Åë°ú½ÃŰ´Â ÀÛ¾÷Àº ½Ã°£ÀÌ ¿À·¡ °É¸®°í ³ôÀº Á¤¹Ðµµ°¡ ÇÊ¿äÇϱ⠶§¹®¿¡ ½Ã°£ÀÌ Ã˹ÚÇÑ ÀÀ±Þ »óȲ¿¡¼­´Â ¹®Á¦°¡ ¹ß»ýÇÕ´Ï´Ù. µû¶ó¼­ ÀÌ·¯ÇÑ À§ÇèÀ» ÁÙÀÌ°í °¡À̵å¿ÍÀÌ¾î »ç¿ëÀÇ ¾ÈÀü¼º°ú È¿À²¼ºÀ» ³ôÀ̱â À§Çؼ­´Â Áö¼ÓÀûÀÎ ±³À°°ú °¡À̵å¿ÍÀÌ¾î ±â¼úÀÇ ¹ßÀüÀÌ ÇʼöÀûÀÔ´Ï´Ù.

°ü»óµ¿¸Æ °¡À̵å¿ÍÀÌ¾î ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº ¹«¾ùÀΰ¡?

°ü»óµ¿¸Æ °¡À̵å¿ÍÀÌ¾î ½ÃÀåÀÇ ¼ºÀåÀº Àü ¼¼°è ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡, °ü»óµ¿¸Æ °¡À̵å¿ÍÀ̾îÀÇ ±â¼ú ¹ßÀü, ÃÖ¼Ò Ä§½ÀÀû ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¼¼°è Àα¸ÀÇ °í·ÉÈ­·Î ÀÎÇØ Á׻󵿸ưæÈ­Áõ°ú °°Àº °ü»óµ¿¸Æ ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ·Î ÀÎÇØ ÁßÀçÀû ½ÉÀåÇÐ ½Ã¼ú¿¡ ´ëÇÑ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °¡À̵å¿ÍÀÌ¾î ±â¼úÀÇ ¹ßÀüÀ¸·Î ½Ã¼ú ¼º°ø·üÀÌ ³ô¾ÆÁö°í ÇÕº´ÁõÀÌ °¨¼ÒÇÔ¿¡ µû¶ó ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üµéÀÌ ÀÌ ½Ã¼úÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ȸº¹ ½Ã°£À» ´ÜÃàÇÏ°í °¨¿° À§ÇèÀ» ÁÙÀ̱â À§ÇÑ ÃÖ¼Òħ½ÀÀû ¼ö¼úÀÌ ÀÇ·á ½Ã½ºÅÛ°ú ȯÀÚµéÀÇ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­ °ü»óµ¿¸Æ °¡À̵å¿ÍÀ̾î¿Í °°Àº Àåºñ¿¡ ´ëÇÑ ¼ö¿äµµ Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ½ÅÈï ½ÃÀåÀÇ ÀÇ·á ÀÎÇÁ¶ó È®´ë¿Í ÀÇ·áºñ Áõ°¡¿Í °°Àº °æÁ¦Àû ¿äÀεµ °ü»óµ¿¸Æ °¡À̵å¿ÍÀÌ¾î ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç, °ü»óµ¿¸Æ °¡À̵å¿ÍÀ̾î´Â ÃֽнÉÀå Ä¡·á ¼Ö·ç¼ÇÀÇ Áß¿äÇÑ ±¸¼º ¿ä¼Ò·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹½Ã(ÃÑ 42°Ç)

  • Abbott Vascular
  • AMG International
  • Asahi Intecc Co.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • BrosMed Medical Co.
  • Comed B.V.
  • Cordis Corporation
  • EPflex Feinwerktechnik GmbH
  • GaltNeedleTech
  • Lepu Medical Technology£¨Beijing£©Co.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Optimed Medizinische Instrumente GmbH
  • Rontis AG.
  • SP Medical A/S
  • Teleflex Inc.
  • Terumo Medical Corporation

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå °³¿ä
  • ÁÖ¿ä ±â¾÷
  • ½ÃÀå µ¿Çâ°ú ÃËÁø¿äÀÎ
  • ¼¼°è ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ºÐ¼®

  • ¹Ì±¹
  • ij³ª´Ù
  • ÀϺ»
  • Áß±¹
  • À¯·´
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • ÀÌÅ»¸®¾Æ
  • ¿µ±¹
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ±âŸ Áö¿ª

Á¦4Àå °æÀï

LSH 24.09.04

Global Coronary Guidewires Market to Reach US$807.2 Million by 2030

The global market for Coronary Guidewires estimated at US$597.2 Million in the year 2023, is expected to reach US$807.2 Million by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Nitinol-Based Guidewires, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$550.2 Million by the end of the analysis period. Growth in the Steel-Based Guidewires segment is estimated at 8.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$160.8 Million While China is Forecast to Grow at 4.3% CAGR

The Coronary Guidewires market in the U.S. is estimated at US$160.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$128.9 Million by the year 2030 trailing a CAGR of 4.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 3.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Coronary Guidewires Market - Key Trends and Drivers Summarized

Heart Trouble on the Rise: The World's Growing Cardio Crisis

The global burden of cardiovascular diseases (CVDs) is escalating at an alarming rate, making it the leading cause of death worldwide. Factors such as aging populations, urbanization, and lifestyle changes—including increased consumption of unhealthy foods, reduced physical activity, and tobacco use—contribute significantly to the prevalence of heart diseases. Modern lifestyles not only predispose individuals to risk factors like hypertension, obesity, and diabetes but also exacerbate the challenges healthcare systems face in managing the rising tide of heart-related ailments. Each year, millions of people are diagnosed with CVDs, stressing the urgent need for enhanced preventive measures, broader public health campaigns, and more accessible treatment options to stem the tide of this growing epidemic. As countries grapple with the healthcare demands of their populations, the heart health of millions hangs in the balance, pressing governments and organizations worldwide to prioritize cardiovascular care and research.

Navigating the Heart's Labyrinths: How Do Coronary Guidewires Make a Difference?

Coronary guidewires are slender wires used by cardiologists to navigate through the complex vascular system of the heart during procedures such as angioplasty or stent placements. These wires act as a guide for catheters and other devices, allowing for accurate positioning and delivery of treatment to blocked or narrowed arteries, which are often symptoms of coronary artery disease. The flexibility and strength of coronary guidewires are critical, as they must safely traverse delicate blood vessels without causing damage. Typically made from a core of stainless steel or nitinol, these wires are engineered with a hydrophilic coating that reduces friction, enabling smoother navigation through tight and tortuous arterial pathways. This precise maneuverability is essential for the success of interventional procedures, directly impacting patient outcomes by restoring proper blood flow and reducing the risk of heart attacks.

What Innovations Are Shaping the Future of Coronary Guidewires?

The evolution of coronary guidewires over recent years has been marked by significant technological advancements aimed at enhancing their usability and effectiveness in catheter-based procedures. Modern guidewires offer advanced features such as enhanced torque control, which allows physicians to direct the wire more precisely. Additionally, the development of hybrid guidewires, which combine different features such as flexibility and stiffness in various sections of the wire, cater to specific procedural needs and complexities. Innovations in material science have also led to the production of guidewires with micro-coated surfaces that improve trackability and reduce vascular trauma. These technological enhancements not only refine the procedure by making it safer and more efficient but also expand the potential of minimally invasive techniques in treating more complex cases of coronary artery disease.

What Challenges and Risks Are Associated with the Use of Coronary Guidewires?

Despite their pivotal role in cardiac catheterization, the use of coronary guidewires is not without risks and challenges. One of the primary concerns is the potential for arterial damage, which can occur if the wire accidentally exits the vascular pathway. Such incidents, though rare, can lead to serious complications, including blood vessel perforation and subsequent bleeding. Additionally, the selection of an appropriate guidewire for a specific procedure requires significant skill and experience from the operating physician, as the choice depends heavily on the anatomical challenges of the patient’s coronary arteries. The process of threading the guidewire can also be time-consuming and requires a high level of precision, posing challenges in emergency situations where time is critical. Therefore, continuous training and advancements in guidewire technology are crucial to mitigate these risks and enhance the safety and efficacy of their use.

What Drives the Growth in the Coronary Guidewires Market?

The growth in the coronary guidewires market is driven by several factors, including the rising prevalence of cardiovascular diseases globally, technological advancements in coronary guidewires, and the increasing demand for minimally invasive procedures. As the global population ages, the incidence of coronary artery diseases such as atherosclerosis rises, subsequently increasing the need for interventional cardiology procedures. The advancements in guidewire technology that offer greater procedural success rates and reduced complications are also encouraging their adoption among healthcare providers. Additionally, as healthcare systems and patients increasingly prefer minimally invasive surgeries for their shorter recovery times and lower infection risks, the demand for devices such as coronary guidewires that facilitate these procedures continues to grow. Economic factors such as expanding healthcare infrastructure in emerging markets and increased healthcare spending also contribute to the expansion of the coronary guidewires market, ensuring it remains a vital component of modern cardiac care solutions.

Select Competitors (Total 42 Featured) -

  • Abbott Vascular
  • AMG International
  • Asahi Intecc Co., Ltd.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • BrosMed Medical Co., Ltd.
  • Comed B.V.
  • Cordis Corporation
  • EPflex Feinwerktechnik GmbH
  • GaltNeedleTech
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Optimed Medizinische Instrumente GmbH
  • Rontis AG.
  • SP Medical A/S
  • Teleflex Inc.
  • Terumo Medical Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Coronary Guidewires - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Economic Update
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Minimally Invasive Cardiac Procedures Drive Demand for Coronary Guidewires
    • Rising Global Prevalence of Coronary Artery Disease Spurs Market Growth
    • Increased Healthcare Spending in Emerging Markets Propels Guidewire Adoption
    • Aging Population Worldwide Sustains Growth in Coronary Intervention Procedures
    • Insurance Coverage Impact Market Dynamics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Coronary Guidewires by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Coronary Guidewires by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Coronary Guidewires by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Nitinol-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Nitinol-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Nitinol-Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Steel-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Steel-Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Steel-Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Cath Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Cath Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Cath Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Coronary Guidewires Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Coronary Guidewires Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Coronary Guidewires Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Coronary Guidewires Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Coronary Guidewires Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Coronary Guidewires by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Coronary Guidewires by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Coronary Guidewires by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • Coronary Guidewires Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Coronary Guidewires Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Coronary Guidewires Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Rest of Europe 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Coronary Guidewires Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Asia-Pacific 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for Coronary Guidewires by Material - Nitinol-Based and Steel-Based - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for Coronary Guidewires by Material - Nitinol-Based and Steel-Based Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of World 16-Year Perspective for Coronary Guidewires by Material - Percentage Breakdown of Value Sales for Nitinol-Based and Steel-Based for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Coronary Guidewires by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Coronary Guidewires by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030

IV. COMPETITION

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦